Clinical Trial Update: Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients

View source ↗

Summary

This clinical trial update covers apalutamide in metastatic hormone-sensitive prostate cancer. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer

Drugs mentioned

• Apalutamide (apalutamide)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Status: ACTIVE_NOT_RECRUITING